Kardigan Inc
KARDHealthcare|Biotechnology|USA
$24.55
+0.18 (+0.76%)
Upcoming Data Readouts (3)
Dec 2026
Est. completion
P2Hypertension
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
NCT07511361n=140
Sep 2027
Est. completion
P2P3Symptomatic Genetic Dilated Cardiomyopathy
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07210723n=332
Aug 2028
Est. completion
P2P3Moderate Aortic Valve Stenosis
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
NCT07001800n=1,276